SYS-CON MEDIA Authors: Elizabeth White, Pat Romanski, Mat Mathews, PR.com Newswire, David Smith

News Feed Item

Cameco Provides Date for Q1 Results and Conference Call

SASKATOON, SASKATCHEWAN -- (Marketwired) -- 03/28/14 -- ALL AMOUNTS ARE STATED IN CDN $ (UNLESS NOTED)

Cameco (TSX: CCO) (NYSE: CCJ) will issue its first quarter results before markets open on Tuesday, April 29, 2014.

Cameco invites investors and the media to join its first quarter conference call with the company's senior executives on Tuesday, April 29, 2014 at 1:00 p.m. Eastern.

Cameco will discuss the financial results and company developments before opening the call to questions from investors and the media.

To join the call, please dial (866) 223-7781 (Canada and US) or (416) 340-2216. An operator will put your call through. A live audio feed of the conference call will be available from a link on cameco.com.

A recorded version of the proceedings will be available on our website, shortly after the call, and on post view until midnight, Eastern, May 30, 2014, by calling (800) 408-3053 (Canada and US) or (905) 694-9451 (Passcode 9624310#).

Profile

Cameco is one of the world's largest uranium producers, a significant supplier of conversion services and one of two CANDU fuel manufacturers in Canada. Our competitive position is based on our controlling ownership of the world's largest high-grade reserves and low-cost operations. Our uranium products are used to generate clean electricity in nuclear power plants around the world. We also explore for uranium in the Americas, Australia and Asia. Our shares trade on the Toronto and New York stock exchanges. Our head office is in Saskatoon, Saskatchewan.

Contacts:
Cameco
Investor inquiries:
Rachelle Girard
(306) 956-6403

Media inquiries:
Rob Gereghty
(306) 956-6190

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.